Inventor · disambiguated record
Youngro Byun
Also filed as: BYUN YOUNGRO
13 granted patents·9 pending applications·620 citations·filing 1999–2023
92Inventor score
Files withMEDIPLEX CORP KOREA7SEOUL NAT UNIV R&DB FOUNDATION4BYUN YOUNGRO3PHAROSGEN CO LTD3MEDIPLEX CORP1
Top patents by PatentIndex Score
22 records- 0197US6245753B1Amphiphilic polysaccharide derivativesMEDIPLEX CORP KOREA·Filed 1999·Granted Jun 12, 2001·289 cites·22 claims
- 0295US6702850B1Multi-coated drug-eluting stent for antithrombosis and antirestenosisMEDIPLEX CORP KOREA·Filed 2002·Granted Mar 9, 2004·236 cites·29 claims
- 0386US6656922B2Oral delivery of macromoleculesMEDIPLEX CORP KOREA·Filed 2001·Granted Dec 2, 2003·21 cites·22 claims
- 0485US6589943B2Formulation of amphiphilic heparin derivatives for enhancing mucosal absorptionMEDIPLEX CORP KOREA·Filed 2001·Granted Jul 8, 2003·22 cites·40 claims
- 0583US10501549B2Methods of inhibiting pathological angiogenesis with doppel-targeting moleculesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2017·Granted Dec 10, 2019·3 cites·18 claims
- 0680US10202459B2Methods of inhibiting pathological angiogenesis with doppel-targeting moleculesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2016·Granted Feb 12, 2019·2 cites·14 claims
- 0776US6624141B1Protamine fragment compositions and methods of useUNIV MICHIGAN·Filed 1999·Granted Sep 23, 2003·32 cites·89 claims
- 0871US7906137B2Delivery agents for enhancing mucosal absorption of therapeutic agentsMEDIPLEX CORP KOREA·Filed 2004·Granted Mar 15, 2011·8 cites·11 claims
- 0968US7638158B2Drug release from antithrombogenic multi-layer coated stentMEDIPLEX CORP KOREA·Filed 2004·Granted Dec 29, 2009·4 cites·19 claims
- 1066US9775914B2Prodrugs activated by caspasePHAROSGEN CO LTD·Filed 2015·Granted Oct 3, 2017·1 cites·50 claims
- 1160US8088753B2Heparin conjugates and methodsBYUN YOUNGRO·Filed 2008·Granted Jan 3, 2012·2 cites·18 claims
- 1259US2024091372A1Anti-doppel antibody drug conjugatesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2023·Application pending·0 cites
- 1353US2004152663A1Formulation of amphiphilic heparin derivatives for enhancing mucosal absorptionFiled 2003·Application pending·0 cites
- 1451US10357572B2Prodrugs activated by caspasePHAROSGEN CO LTD·Filed 2017·Granted Jul 23, 2019·0 cites·30 claims
- 1551US2025302981A1Novel use of anticancer agent prodrug conjugateUNIV ULSAN FOUND IND COOP·Filed 2021·Application pending·0 cites
- 1651US2004220143A1Oral delivery of macromoleculesMEDIPLEX CORP KOREA·Filed 2003·Application pending·0 cites
- 1751US2007021325A1Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeabilityMEDIPLEX CORP·Filed 2005·Application pending·0 cites
- 1851US2010021538A1Pharmaceutical compositions containing heparin derivativesBYUN YOUNGRO·Filed 2009·Application pending·0 cites
- 1951US2020022997A1Oral anticancer prodrugs, their preparation methods and applicationsSEOUL NAT UNIV R&DB FOUNDATION·Filed 2019·Application pending·0 cites
- 2050US2005101532A1Protamine fragment compositions and methods of useFiled 2003·Application pending·0 cites
- 2145US11912760B2Doppel-targeting antibodiesPHAROSGEN CO LTD·Filed 2021·Granted Feb 27, 2024·0 cites·27 claims
- 2243US2011237504A1Delivery agents for enhancing mucosal absorption of therapeutic agentsBYUN YOUNGRO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Youngro Byun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →